Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で24.67%の成長率を示しています。
黒字転換
同社は黒字転換を果たし、最新の年間純利益はUSD です。
割高
同社の最新のPEは88.74で、過去3年間の水準と比較して高値圏にあります。
機関投資家の買い増し
最新の機関投資家の保有株数は45.29M株で、前四半期比で1.10%増加しています。
HACAXが保有
スター投資家HACAXは本銘柄を130.00株保有しています。
市場活動が活発
同社への投資家の関心が高まっており、20日間の売買回転率は0.76です。